Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Capital Expenditures: 2014-2022

Historic Capital Expenditures for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Sep 2022 value amounting to $716,000.

  • Avadel Pharmaceuticals' Capital Expenditures was N/A to $716,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $840,000, marking a year-over-year change of. This contributed to the annual value of $716,000 for FY2022, which is 2653.85% up from last year.
  • According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Capital Expenditures is $716,000, which was up 2,653.85% from $26,000 recorded in Q1 2021.
  • Over the past 5 years, Avadel Pharmaceuticals' Capital Expenditures peaked at $716,000 during Q3 2022, and registered a low of -$1,000 during Q2 2019.
  • Its 3-year average for Capital Expenditures is $210,000, with a median of $49,000 in 2020.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Capital Expenditures skyrocketed by 546.15% in 2018 and then tumbled by 101.72% in 2019.
  • Over the past 5 years, Avadel Pharmaceuticals' Capital Expenditures (Quarterly) stood at $11,000 in 2018, then tumbled by 101.72% to -$1,000 in 2019, then reached $65,000 in 2020, then reached $26,000 in 2021, then reached $716,000 in 2022.
  • Its last three reported values are $716,000 in Q3 2022, $26,000 for Q1 2021, and $65,000 during Q4 2020.